SYTRON

This brand name is authorized in Estonia, United Kingdom

Active ingredients

The drug SYTRON contains one active pharmaceutical ingredient (API):

1 Sodium feredetate UNII 403J23EMFA - SODIUM FEREDETATE

Sodium feredetate is used for iron deficiency anaemia. After absorption, elemental iron is available for haemoglobin regeneration and reversal of anaemia associated with iron-deficient states. Read about Sodium feredetate

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SYTRON Oral solution	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B03A	Iron preparations	B Blood and blood forming organs → B03 Antianemic preparations
Discover more medicines within B03A

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1695135
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 24884